Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Centro Elpis
Lexington, MA, United Statescentroelpis.it ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Elpis Biopharmaceuticals develops next-generation cell therapies using proprietary multi-mechanism armored CAR-T platforms designed to overcome tumor heterogeneity and immunosuppressive microenvironments. Lead assets target solid tumors such as glioblastoma, with additional programs addressing hematological cancers like AML and multiple myeloma. The company’s technologies integrate bispecific targeting antibodies, cytokine engineering, advanced manufacturing processes, and rapid antibody/protein discovery engines. Early data show potent tumor regression at low doses with robust immune modulation.
- Therapeutic areas
- HematologyOncology
- Modalities
- CAR-T cell therapy (including bispecific armored CAR-T)Bispecific antibodyImmunomodulator protein therapeuticsDual targeting tandem CAR-T cells
- Industry
- Biotech
02
Partnerships
Singapore General Hospital – research collaboration on allogeneic next-generation cell therapies targeting AML & MM.
Beyond the preview
Go deeper on Centro Elpis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Centro Elpis.